IRadimed

IRMD · NASDAQ

$88.24+$0.59 (+0.67%)TodayMarket closed ·
Prev close $87.65

About IRMD

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. The company is headquartered in Orlando, Florida and currently employs 166 full-time employees. The company went IPO on 2014-07-16. Its MRidium 3860+ MRI Compatible IV infusion pump system provides a non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to deliver anesthesia safely and predictably and other IV medications or fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to monitor a patient’s vital signs safely and accurately during various MRI procedures. The firm sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably in magnetic fields up to 30,000 gauss.

Employees
166
Headquarters
Orlando, Florida
Listed
Jul 16, 2014
Sector
Health Care
Industry
Health Care Equipment & Supplies

Leadership

IRadimed executives
NameTitleSince
Roger Susi—2020
John Glenn——
Randy Waddell——
Jeffrey Chiprin——
James Hawkins—2013
Monty Allen——
Joe Kiani——
Hilda Scharen-Guivel——

Revenue by product and region

Fiscal year ended Dec 31, 2024: $73.24M total revenue

By region

  • UNITED STATES$60.61M82.7%
  • Represents information pertaining to International, a geographic region of the entity.$12.64M17.3%

Suppliers and customers

Price correlation is over one year: 1 means the stocks move together, -1 opposite

IRadimed suppliers and customers
CompanyRelationshipCorrelation
Masimo MASISupplier and customer-0.24
E For L AIM EFORLCustomer—

Similar companies

Companies in the same industry as IRadimed

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.